Microfluidic Technologies for cfDNA Isolation and Analysis

Area of Science:

• Biotechnology
• Molecular Biology
• Oncology

Background:

• Cell-free DNA (cfDNA) is crucial in precision oncology for informing genomic mutations, tumor burden, and drug resistance.
• Absolute quantification of cfDNA concentration serves as an independent prognostic biomarker for overall survival.
• Low abundance and high fragmentation of cfDNA present significant challenges for isolation and analysis.

Purpose of the Study:

• To review existing and potential applications of microfluidic technologies in cfDNA analysis.
• To highlight how microfluidics can address limitations in cfDNA isolation and quantification.
• To discuss future perspectives for microfluidic applications in cfDNA-based diagnostics.

Main Methods:

• Review of current literature on microfluidic technologies for cfDNA.
• Analysis of microfluidic platforms for sample handling at the micrometer scale.
• Exploration of automated and high-throughput cfDNA screening methods.

Main Results:

• Microfluidic and lab-on-a-chip (LOC) devices enable handling of small cfDNA sample volumes.
• These technologies facilitate rapid cfDNA isolation and potential for simultaneous examination and quantification.
• Microfluidic platforms offer automation and high-throughput screening, reducing manual liquid transfer.

Conclusions:

• Microfluidic technologies present a significant opportunity to advance cfDNA isolation, enrichment, and analysis.
• Further exploration and development of microfluidic applications are needed for comprehensive cfDNA diagnostics.
• These technologies can enhance precision oncology by enabling more efficient and accurate cfDNA analysis.